Procedures for fetal neuroprotection: use of magnesium sulfate.

Universidade Federal de Sao Paulo (UNIFESP) Escola Paulista de Medicina Obstetrics Department

[1]  Caroline A Crowther,et al.  Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol , 2013, BMC Pregnancy and Childbirth.

[2]  C. Crowther,et al.  Magnesium sulphate for women at term for neuroprotection of the fetus. , 2013, The Cochrane database of systematic reviews.

[3]  J. Fullerton,et al.  An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management , 2013, BMC Pregnancy and Childbirth.

[4]  Patient safety checklist No. 7: magnesium sulfate before anticipated preterm birth for neuroprotection. , 2012, Obstetrics and gynecology.

[5]  A. Synnes,et al.  SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[6]  O. Luria,et al.  Effect of vaginal progesterone, administered to prevent preterm birth, on impedance to blood flow in fetal and uterine circulation , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[7]  Jagjit Singh,et al.  Magnesium for neuroprotection in birth asphyxia , 2010, Journal of pediatric neurosciences.

[8]  R. Bittar,et al.  Indicadores de risco para o parto prematuro , 2009 .

[9]  M. Zugaib,et al.  [Risk predictors for preterm birth]. , 2009, Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia.

[10]  L. Doyle,et al.  Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. , 2009, The Cochrane database of systematic reviews.

[11]  K. Nelson,et al.  Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. , 2000, American journal of obstetrics and gynecology.

[12]  J. Canterino,et al.  Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage. , 1999, Obstetrics and gynecology.

[13]  G. Thurnau,et al.  The effect of maternal magnesium sulfate treatment on neonatal morbidity in < or = 1000-gram infants. , 1998, American journal of perinatology.

[14]  C. Shen,et al.  Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants. , 1997, American journal of perinatology.

[15]  C. Berg,et al.  Prenatal Magnesium Sulfate Exposure and the Risk for Cerebral Palsy or Mental Retardation Among Very Low-Birth-Weight Children Aged 3 to 5 Years , 1996 .

[16]  K. Nelson,et al.  Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? , 1995, Pediatrics.